NYSE:IBIO
Ibio Inc Stock News
$2.00
+0.0100 (+0.503%)
At Close: May 07, 2024
iBio Inc. Shares Approach 52-Week Low - Market Mover
01:31am, Friday, 07'th Jan 2022 Kwhen Finance
iBio Inc. (IBIO) shares closed today at 1.9% above its 52 week low of $0.53, giving the company a market cap of $117M. The stock is currently down 1.6% year-to-date, down 54.2% over the past 12 months, and down 88.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 5.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -16.7% The company's stock price performance over the past 12 months lags the peer average by 66.5%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
iBio Announces Participation in the H.C. Wainwright BioConnect Conference
09:30pm, Tuesday, 04'th Jan 2022 GlobeNewswire Inc.
BRYAN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-bas
Astounding Stock: Greenpro Capital Corp. (NASDAQ:GRNQ), iBio, Inc. (AMEX:IBIO)
04:40am, Friday, 24'th Dec 2021 Stock Equity
Greenpro Capital Corp. (NASDAQ:GRNQ) with the stream of -1.82% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of 0.76% in the last hour of Thursdays trading session. Greenpro The post Astounding Stock: Greenpro Capital Corp. (NASDAQ:GRNQ), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .
iBio Inc. (IBIO) Rises From The Low: Could It Be A Catbird Seat?
01:00pm, Thursday, 23'rd Dec 2021 Stocks Register
iBio Inc. (AMEX:IBIO) concluded the trading at $0.66 on Wednesday, December 22 with a rise of 1.54% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.65 and 5Y monthly beta was reading -6.24 with its price kept floating in the range iBio Inc. (IBIO) Rises From The Low: Could It Be A Catbird Seat? Read More »
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
02:25pm, Wednesday, 22'nd Dec 2021 GlobeNewswire Inc.
- Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin - - Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Marg
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
02:25pm, Wednesday, 22'nd Dec 2021 Intrado Digital Media
- Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin - - Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -
iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting
02:20pm, Tuesday, 21'st Dec 2021 GlobeNewswire Inc.
BRYAN, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-bas
Valuing Stock Using Ratios and Multiples: Histogen Inc. (NASDAQ:HSTO), iBio, Inc. (AMEX:IBIO)
12:53am, Monday, 20'th Dec 2021 Stock Equity
Histogen Inc. (NASDAQ:HSTO) with the stream of 2.34% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of 6.16% in the last hour of Fridays trading session. Histogen Inc. The post Valuing Stock Using Ratios and Multiples: Histogen Inc. (NASDAQ:HSTO), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .
iBio Inc.s (AMEX: IBIO) Stock Price Continues To Fall
12:00pm, Wednesday, 15'th Dec 2021 Stocks Register
The trading price of iBio Inc. (AMEX:IBIO) closed lower on Tuesday, December 14, closing at $0.65, -2.29% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy
Captivating Stock: Tuniu Corporation (NASDAQ:TOUR), iBio, Inc. (AMEX:IBIO)
12:19am, Wednesday, 15'th Dec 2021 Stock Equity
Tuniu Corporation (NASDAQ:TOUR) with the stream of -1.32% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of -2.29% in the last hour of Tuesdays trading session. Tuniu Corporation The post Captivating Stock: Tuniu Corporation (NASDAQ:TOUR), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .
Tuniu Corporation, NASDAQ:TOUR, TOUR NEWS, TOUR STOCK, iBio, Inc., AMEX:IBIO, IBIO NEWS, IBIO STOCK, TOUR, IBIO
12:19am, Wednesday, 15'th Dec 2021 Stock Equity
Cyren Ltd. (NASDAQ:CYRN) with the stream of -5.83% also noticed, India IT Tech Packaging, Inc. (AMEX:ITP) encountered a rapid change of -2.38% in the last hour of Tuesdays trading session. The post Tuniu Corporation, NASDAQ:TOUR, TOUR NEWS, TOUR STOCK, iBio, Inc., AMEX:IBIO, IBIO NEWS, IBIO STOCK, TOUR, IBIO appeared first on Stocks Equity .
iBio Inc. (AMEX: IBIO): Blank Check On Growth?
05:10pm, Friday, 10'th Dec 2021 Stocks Register
iBio Inc. (AMEX:IBIO) price on Friday, December 10, fall -4.06% below its previous days close as a downside momentum from buyers pushed the stocks value to $0.67. A look at the stocks price movement, the level at last check in todays session was $0.69, moving within a range at $0.69 and $0.75. The beta value iBio Inc. (AMEX: IBIO): Blank Check On Growth? Read More »
iBio Announces Partial Adjournment of Annual Meeting to December 22
01:30pm, Friday, 10'th Dec 2021 GlobeNewswire Inc.
- Shareholders Presently Supporting Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -
Technology - IBio Upgraded to Hold by Zacks Investment Research
08:45am, Tuesday, 07'th Dec 2021 Business Mag
Zacks Investment Research upgraded shares of iBio from a sell rating to a hold rating in a research report released on Monday morning, Zacks.com reports. According to Zacks
iBio (NYSEAMERICAN:IBIO) Upgraded to Hold by Zacks Investment Research
05:08am, Tuesday, 07'th Dec 2021 Dakota Financial News
iBio (NYSEAMERICAN:IBIO) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a research note issued on Monday, Zacks.com reports. According to Zacks, Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. []